PULSE BIOSCIENCES, INC. Logo

PULSE BIOSCIENCES, INC.

Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.

PLSE | NDAQ

Overview

Corporate Details

ISIN(s):
US74587B1017
LEI:
Country:
United States of America
Address:
3957 POINT EDEN WAY, 94545 HAYWARD
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Pulse Biosciences, Inc. is a bioelectric medicine company developing a proprietary therapeutic platform based on Nanosecond Pulsed Field Ablation (nsPFA) technology. This novel, nonthermal energy modality is designed to precisely ablate cellular tissue while sparing adjacent noncellular structures. The company's primary focus is on advancing treatments in cardiology, particularly for atrial fibrillation, through its investigational CellFX® nsPFA™ 360 Cardiac Catheter and Cardiac Clamp. Pulse Biosciences is also expanding its nsPFA technology into other medical applications, including the development of a percutaneous electrode for the treatment of benign thyroid nodules. The company is actively advancing its product pipeline through clinical studies and regulatory submissions to establish nsPFA as a new standard of care in various medical procedures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PULSE BIOSCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PULSE BIOSCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PULSE BIOSCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NOSA Plugs AB Logo
Develops intranasal products for odor control, allergy relief, and smell recovery for B2C/B2B.
Sweden NOSA
Noul Co., Ltd. Logo
AI-powered, automated point-of-care diagnostics for accessible global healthcare.
South Korea 376930
Nuwellis, Inc. Logo
Develops an ultrafiltration system to remove excess fluid from diuretic-resistant patients.
United States of America NUWE
Nyxoah SA Logo
Develops a mask-free, minimally invasive neurostimulation implant to treat Obstructive Sleep Apnea.
United States of America NYXH
OMNICELL, INC. Logo
Automating medication management for healthcare providers with robotics and intelligent software.
United States of America OMCL
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Logo
Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.
Türkiye ONCSM
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Canada OBI
Onward Medical N.V. Logo
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
Netherlands ONWD
Orchestra BioMed Holdings, Inc. Logo
Develops bioelectronic & drug/device therapies for hypertension and artery disease.
United States of America OBIO
Organogenesis Holdings Inc. Logo
Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.
United States of America ORGO

Talk to a Data Expert

Have a question? We'll get back to you promptly.